Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results

Gynecologic Oncology

Volumn 67, Issue 1, 1997, Pages 61-69

  Sardi, Juan E ^a   Giaroli, Adolfo ^a   Sananes, Carlos ^a   Ferreira, Marta ^a   Soderini, Alejandro ^a   Bermudez, Adriana ^a   Snaidas, Lazaro ^a   Vighi, Susana ^a   Rueda, Nidia Gomez ^a   Di Paola, Guillermo ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; VINCRISTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0031259959     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4812     Document Type: Article

References (54)

1. 1. Petterson F (Ed) Annual Report on the Results of Treatment in Gynecological Cancer, Stockholm, 1991, Vol 20
2. 2. Van Nagell J, Donaldson E, Parke J, et al: The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery. Gynecol Oncol 5: 142, 1977
3. 3. Hass J: Tumormetric Measurements and Morphometry in Cervical Cancer, in Burghardt E, Monaghan JM (eds): Clinical Obstetrics and Gynecology, London, Bailliere-Tindal, 1989, p 871
4. 4. Alvarez R, Soong S, Kinney W, et al: Identification of prognostic factors and risk groups in patients found to have nodal metastases at the time of radical hysterectomy for early stage squamous carcinoma of the cervix. Gynecol Oncol 35:130-135, 1989
5. 5. Piver M, Chung W: Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 46:507, 1975
6. 6. Hoskins W: Prognostic Factors for Risk of Recurrence in Stage Ib and IIa Cervical Cancer, in Burghardt E, Monaghan JM (eds): Clinical Obstetrics and Gynecology, London, Baillere-Tindal, 1989, p 817
7. 7. Fuller A, Elliot N, Kosloff C, et al: Determinants increased risk of recurrence in patients undergoing radical surgery for stage Ib and IIa carcinoma of the cervix. Gynecol Oncol 32:146, 1988
8. 8. Landoni F, Bocciolone L, Perego P, Maneo A, et al: Cancer of the cervix, FIGO Stages Ib and IIa: patterns of local growth and paracervical extension. Int J Gynecol Cancer 5(5):329-334, 1995
9. 9. Zanetta G, Colombo A, Milani R, Placa F, Mangioni G: Long-term results of sequential postoperative treatment with vincristine, bleomycin, mitomycin-c, cis-platin and radiotherapy after surgery for high-risk patients with cervical carcinoma Stage Ib-IIa. Int J Gynecol Cancer 5(1):40-44, 1995
10. 10. Friedlander M, Atkinson K, Coppleson J, et al: The integration of chemotherapy in locally advanced carcinoma of the cervix. Gynecol Oncol 19:1, 1984
11. 11. Sardi J, Di Paola G, Sananes C, et al: A possible new trend in the management of the carcinoma cervix uteri. Gynecol Oncol 25:139, 1986
12. 12. Rustin G, Newlands E, et al: cis-Platinum, vincristine, methotrexate and bleomycin as initial or palliative chemotherapy for carcinoma of the cervix. Eur J Gynecol Oncol 8:337, 1987
13. 13. Kim D, Moon H, Hwang Y, et al: Preoperative adjuvant chemotherapy in the treatment of cervical cancer with bulky tumor. Gynecol Oncol 29:322, 1988
14. 14. Valle J, Rezende M, et al: Neoadjuvant and adjuvant chemotherapy with ABC and modified radical hysterectomy in cancer of the cervix stage III. Proc Am Soc Clin Oncol 4:c486, 1985 [abstract]
15. 15. Sardi J, Sananes C, Giaroli A: Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 8:486-493, 1990
16. 16. Sardi J, Sananes C, Giaroli A, et al: Results of a prospective randomized trial with neoadjuvant chemotherapy in stage Ib, bulky, squamous carcinoma of the cervix. Gynecol Oncol 49:166-165, 1993
17. 17. Kaplan E, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457, 1958
18. 18. Peto R, Pike M, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II analysis and examples. Br J Cancer 35:1, 1978.
19. 19. Cox DR: Regression models and life tables. JR Stat Soc 34:187, 1972
20. 20. Alvarez RD, Potter M, Soong S, et al: Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage Ib cervical cancer patients. Gynecol Oncol 43:108-112, 1991
21. 21. Mendenhall W, Thor T, Bova V, et al: Prognostic and treatment factors affecting pelvic control of stage Ib and II a-b carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 53:2649, 1984
22. 22. Rutledge F, Smith J, Fletcher G: Clinical studies with adjunctive surgery and irradiation therapy in carcinoma of the cervix uteri. Cancer 38:596, 1976
23. 23. Weems D, Mendenhall W, Bova F, et al: Carcinoma of the uterine cervix stage Ib-IIa-IIb. 6 cm. in diameter: Irradiation alone vs preoperative irradiation and surgery. Int J Radiat Oncol Biol Phys 11:1911, 1985
24. 24. Gaddis O Jr, Morrow CP, Klement V, et al: Treatent of cervical carcinoma employing a template for transperineal instertitial iridium braquitherapy. Int J Radiat Oncol Biol Phys 9:819, 1983
25. 25. Perez C, Koo M: Radiation therapy alone or combined with surgery in the treatment of barrel-shaped carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 11:1903, 1985
26. 26. Perez CA, Grisby PW, Camel HM, et al: Irradiation alone or combined with surgery in stage Ib, IIa, and IIb carcinoma of the uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 31:703-716, 1995
27. 27. Bloss J, Berman M, Manetta A, et al: Bulky staged Ib cervical carcinoma manged by primary radical histerectomy followed by tailored radiotherapy. Gynecol Oncol 47:21, 1992
28. 28. Thomas GM: Is neoadjuvant chemotherapy a useful strategy for the treatment of stage Ib cervix cancer? Gynecol Oncol 49:153-155, 1993
29. 29. Lai C, Hsueh S, Chang T; et al: Prognostic factors in patients with bulky stage Ib or IIa cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 64:456-462, 1997
30. 30. Di Paola, G, Sardi J, [letter to the editor]. Gynecol Oncol 55:156-157, 1994
31. 31. Potish R, Downey Gordon, Adcock Leon, et al: The role of surgical debulking in cancer of the uterine cervix. Int J Radiat Oncology Biol Phys 17:979-984, 1989
32. 32. Pickel H, Maas J, Lahousen M: Prognostic Factors in Cervical Cancer: Operative Treatment of Cervical Cancer, London, Bailliere Tindall, 1988, p 805
33. 33. Ferreira M, Snaidas L, Soderini A, Sardi J: Subradical Treatment for Carcinoma of the Cervix Ib, dogma or utopia? European School of Oncology, First Latin American Convention, Buenos Aires, Argentina, November 1995
34. 34. Namkoong SE, Park JS, Kim JN, et al: Comparative study of pacients with locally advanced stages Ib and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol 59:136-142, 1995
35. 35. Burghardt E, Haas J, Girardi F: The Significance of the Parametrium in the Operative Treatment of Cervical Cancer, in Burghardt E, Monaghan JM (eds): Clinical Obstetrics and Gynecology, London, Bailliere-Tindall, 1989, p 879
36. 36. Kutznezoff D, Lombroni J, Gutierrez A, et al: Assessment of local and regional extent of the cervical carcinoma using M.R. imaging transvaginal ultrasonography, and transrectal ultrasonography. J Gynecol-Tech 2:147-154, 1996
37. 37. Benedetti Panici P, Scambia G, Greggi S, et al: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study. Obstet Gynecol 71:344, 1988
38. 38. Gori J, Cataño RI, Puga A, et al: Valoración de la respuesta al VBP vs PF como neoadyuvancia en el cáncer de cuello uterino estadio Ib-II-III. First Argentine Congress of Gynecologic Oncology, 1:14, October 1994 [Abstracts]
39. 39. Giaroli A, Sananes C, Sardi J, et al: Lymph node metastases in carcinoma of the cervix uteri: response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 39:34, 1989
40. 40. Benedetti Panici P, Scambia G, Baiocchi G. et al: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 67:372, 1991
41. 41. Kim D, Moon H, Kim K, et al: Two years survival: preoperative adjuvant chemotherapy in the treatment of cervical cance Stage Ib and II with bulky tumors. Gynecol Oncol 33:225, 1989
42. 42. Chang HC, Lai Ch, Chou PC, et al: Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol 30:281-285, 1992
43. 43. Sardi J, Giaroli A, Sananes N, et al: Randomized trial with neoadjuvant chemotherapy in stage IIIb squamous carcinoma cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer 6:85-93, 1996
44. 44. Lowrey GC, Mendenhall WM, Million RR: Stage Ib or IIa-b carcinoma of the intact uterine cervix treated with irradiation; a multivariate analysis. Int J Radiat Oncol Biol Phys 24:205-210, 1992
45. 45. Montana GS, Owle WC, Varia MA, et al: Carcinoma of the cervix stage Ib; results of treatment with radiation therapy. Int J Radiat Oncol Biol Phys 9:45-49, 1983
46. 46. Perez CA, Grigsby PW, Nene SW, et al: Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 69:2796-2806, 1992
47. 47. Rotman M, Choi K, Guze C, Marcial V, Hornback N, John M: Prophylactic irradiation of the para-aortic lymph node chain in stage IIb and bulky stage Ib carcinoma of the cervix: initial treatment results of RTOG 7920. Int J Radiat Oncol Biol Phys 19:513-521, 1990
48. 48. Kim D, Moon H, Hwang Y. et al: Three and five years survival: neoadjuvant chemotherapy of locally advanced cervical cancer. Int J Gynecol Cancer 3 (Suppl 1):24, 1993
49. 49. Bolis G, Villa A, Guerrerio P, et al: [Letter to the editors]. Gynecol Oncol 61:156-160, 1996
50. 50. Zubizarreta E, Leborgne F, Leborgne J, Induction chemotherapy and radiotherapy of advanced cancer of the cervix. A pilot study and a phase III randomized trial. European School of Oncology. Abstracts of the First Latin American Convention. Buenos Aires, Argentina, November 1995, p 21
51. 51. Horng C, Chyong L, Mingshen C, et al: Preliminary results of radiotherapy and chemotherapy with cis-platinum, vincristine and bleomycin in bulky advanced cervical carcinoma. Gynecol Oncol 44:182, 1992
52. 52. Belloni C, Maschio A, Colombo G, et al: Prospects of neoadjuvant chemotherapy in the treatment of cervical cancer. Cervix 8:209, 1990
53. 53. Bloss J, Lucci J, Di Saia Ph, et al: A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix. Gynecol Oncol 59:105-110, 1995
54. 54. Mondelo N, Molinolo A, Sardi J, et al: Bleomycin. Unpublished data, with permission, in press.